PURPOSE: Transport and Golgi organization protein 1 (TANGO) promotes angiogenesis and lymphangiogenesis in oral squamous cell carcinoma (OSCC). To elucidate the underlying mechanisms, this study aims to identify and characterize elements downstream of TANGO that mediate its involvement in OSCC. METHODS: In this study, microarray analysis compared gene expression between control and TANGO-repressed HSC3 cells. Protein expression in 213 OSCC tissue samples was analyzed immunohistochemically. RESULTS: TANGO repression decreased or increased expression of Mucin 20 (MUC20) and small proline-rich protein 1B (SPRR1B), respectively. MUC20 increased the growth and invasiveness of OSCC cells via altered matrix metalloproteinase (MMP)-2 and E-cadherin expression and c-met phosphorylation. MUC20 induced angiogenesis and lymphangiogenesis by activating vascular endothelial growth factors A and C. In well-differentiated OSCC, SPRR1B expression was high (Pâ=â0.0091) and correlated with keratinization markers and promoted proliferation by inducing mitogen-activated protein kinase p38 phosphorylation. MUC20 expression correlated significantly with clinical stage (Pâ=â0.0024), lymph node metastasis (Pâ=â0.0036), and number of blood and lymph vessels (Pâ<â0.0001). MUC20-expressing cases had a significantly worse prognosis than non-expressing cases (Pâ<â0.0001). CONCLUSION: MUC20 and SPRR1B located downstream of TANGO may be useful molecular markers for OSCC.
Identification of oral squamous cell carcinoma markers MUC2 and SPRR1B downstream of TANGO.
TANGO下游的口腔鳞状细胞癌标志物MUC2和SPRR1B的鉴定
阅读:12
作者:Sasahira Tomonori, Kurihara-Shimomura Miyako, Shimomura Hiroyuki, Bosserhoff Anja Katrin, Kirita Tadaaki
| 期刊: | Journal of Cancer Research and Clinical Oncology | 影响因子: | 2.800 |
| 时间: | 2021 | 起止号: | 2021 Jun;147(6):1659-1672 |
| doi: | 10.1007/s00432-021-03568-9 | 研究方向: | 细胞生物学 |
特别声明
1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。
2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。
3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。
4、投稿及合作请联系:info@biocloudy.com。
